Finally, considering that NSPs partial inhibition reduced IL-1β secretion but did not affect the neutrophil STEC killing capacity, our findings also pave the way to investigate the therapeutic potential of inhibiting NSPs to reduce inflammation associated with STEC infections and in turn the progression to HUS. Here, IL1B is linked to hemolytic-uremic syndrome.